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Background/Introduction: Studies have shown that, in the USA, body dissatisfaction has 
decreased among overweight and obese subjects. Knowledge of trends on how current body 
weight relates to both weight satisfaction and desire to change weight among Swiss adults is 
limited. 
Methods: Cross-sectional data from three National health interview surveys conducted in 
representative samples of the Swiss adult population: 1997 (n=12,474), 2002 (n=18,908) and 
2007 (n=17,879). Weight, height, body dissatisfaction and desire to change weight were assessed 
by questionnaire. 
Results: In 1997, 2002 and 2007 the percentages of overweight individuals dissatisfied with their 
weight was 63%, 67% and 63% in women and 41%, 46% and 42% in men respectively. Among 
obese subjects, the percentages were 77%, 82% and 79% in women and 63%, 73% and 67% in 
men. In overweight men, desire to change weight was 62.9% and 69.9% in 1997 and 2007, 
respectively (79.7% and 88.5% in women). Among obese men the percentages were 82.7% and 
86.2% (86.3% and 91.6% in women). Most (>97%) of the desired changes were towards a 
decrease. Still, a significant percentage (36.1% in 2007) of normal weight men reported a desire to 
increase weight (9.1% in normal weight women). Multivariate analysis revealed that female 
gender, younger age, migrant status, high educational level, former smokers and increased BMI 
were independently and positively associated with body dissatisfaction and desire to change 
weight, while no relationship was found for survey year. 
Conclusion: Contrary to the USA, body dissatisfaction and desire to lose weight remained stable 
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Message of the Vice-Dean for Research 
 
Dear Friends and Colleagues, 
On behalf of the Organizing Committee I would like to welcome you to the ninth 
edition of the CHUV Research Day, which will be dedicated to cardiology and 
metabolism. Clinical and research development in both fields  has been given 
high priority at the CHUV and UNIL, and the coming years should see significant 
progress toward the establishment of corresponding clinical and research 
centres.  
Growing evidence indicates that inflammation is causally related to obesity and 
diabetes. Thus, obesity is associated with low grade systemic inflammation that 
constitutes one of the mechanisms underlying obesity-associated morbidity. 
Moreover, chronic inflammation is a significant risk factor for the development of 
cardiovascular and metabolic disease and continuous secretion of factors such as 
TNFα and IL-6 is associated with increased risk for numerous chronic diseases 
including insulin resistance, atherosclerosis and type 2 diabetes. 
Given that obesity is a complex disorder, a mutidisciplinary approach is 
necessary to unravel its pathogenesis and underlying mechanisms. The use of 
numerous « omic » technologies including genomics, proteomics and 
metabolomics is becoming essential in order to identify inflammatory biomarkers 
that may be implicated in the pathogenesis of obesity and the mechanisms that 
link the increase in adipose mass to morbidity. Once identified, elucidation of the 
role of the relevant inflammatory factors in the various disorders related to 
obesity will be essential.  
Among cardiovascular diseases, atherosclerosis is linked not only to inflammation 
but to an adaptive immune response as well. However, whereas the role of Th1 
lymphocytes in atherogenesis is well established, less is known about the role of 
othee T cell subsets, including Th2 and Th17. Elucidation of the full repretoire of 
mechanisms whereby adaptive immunity enhances atherogenesis will no doubt 
be important. 
The program to which you have been invited will cover a variety of aspects of the 
implication of inflammation and immunity in obesity and atherogenesis with a 
view as to possible novel therapeutic approaches down the line.   
I would like to thank the Scientific Committee for putting together a high quality 
program with a superb panel of guest speakers and hope that you will find the 
event to be both stimulating and enjoyable. 
 
Ivan Stamenkovic 
Vice-Doyen for Research 
Message du Vice-Doyen de la Recherche 
 
Cher(e)s Collègues, Cher(e)s Ami(e)s, 
Je vous souhaite la bienvenue à la neuvième édition de la Journée de Recherche 
CHUV dont les thématiques sont la cardiologie et le métabolisme. Ces 
thématiques représentent des domaines de développement prioritaires du CHUV 
et de l’UNIL et prennent une importance croissante dans notre Faculté. 
Les développements récents dans le domaine du métabolisme indiquent que 
l’inflammation joue un rôle important dans l’obésité et dans le diabète. Ainsi, 
l’obésité est associée à un état inflammatoire systémique chronique de bas grade 
qui constitue l’un des mécanismes potentiels impliqué dans les complications de 
l’obésité. L’inflammation chronique de bas grade est un facteur de risque 
significatif pour les maladies cardiovasculaires et métaboliques, et la sécrétion 
continue des médiateurs tels que le TNFα et l’IL-6 est associée à un risque 
augmenté pour de nombreuses maladies chroniques y compris la résistance à 
l’insuline, l’artériosclérose et le diabète de type II.   
La physiologie de l’obésité étant complexe, il est évident qu’une approche 
multidisciplinaire est nécessaire pour comprendre son processus et les 
mécanismes qui y conduisent. L’utilisation de nouvelles technologies, y compris 
la génomique, la protéomique et la métabolomique devient indispensable afin 
d’identifier les biomarqueurs inflammatoires qui pourraient être impliqués dans la 
pathogénèse de l’obésité ainsi que dans les mécanismes moléculaires qui lient 
l’augmentation la masse du tissu adipeux aux dysfonctions de l’organisme. Il est 
de ce fait essentiel de comprendre le rôle des différents facteurs inflammatoires 
dans les affections liées à l’obésité. 
Parmi les maladies cardiovasculaires, la pathogénèse de ’artériosclérose est 
intimement liée à la réponse immune adaptative. Toutefois, alors que le rôle 
athérogène des lymphocytes Th1 est bien établi, celui des autres sous groupes 
lymphocytaires T, y compris Th2 et Th 17 l’est moins mais de plus en plus de 
données suggèrent que ces lymphocytes participent à la régulation de 
l’artériosclérose et l’élucidation de leur mécanisme d’action sera d’importance.  
Le programme auquel vous êtes conviés fait le point sur les approches actuelles 
de l’analyse de la réponse inflammatoire et immune dans l’obésité et dans 
l’artériosclérose et examine les voies thérapeutiques possibles.  
Je tiens à remercier les membres du comité scientifique pour avoir établi un 
programme stimulant et de très haute qualité et je vous souhaite de passer une 
journée agréable.  
 
Ivan Stamenkovic 
Vice-Doyen de la Recherche 
 Faculty of Biology and Medicine 
FBM RESEARCH DAY 2011 
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Coffee & Poster presentations 
 
  
VASCULAR AGEING VASCULAR AGEING 
 
10:15 PACTT and morning short talks  
16:15 Pierre BOUTOUYRIE  
11:45 Johan AUWERX 
EPFL, Lausanne, Switzerland 







G. Pompidou European Hospital, Paris, France 
Vascular ageing: patholophysiology and basis 
for therapeutics 
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10h15 - 10h30 Stefan KOHLER 
PACTT – UNIL/CHUV 
From the lab to the market: 
Commercialisation of research results 
10h30 – 10h45 Cécile JACOVETTI 
Department of Cellular Biology  
and Morphology - UNIL 
The role of micro-RNAs in beta-cell mass 
expansion during pregnancy 
10h45 – 11h00 Pedro MARQUES-VIDAL 
Social and Preventive Medicine 
CHUV 
Prevalence and management of 
cardiovascular risk factors among 
migrants in Switzerland 
11h00 – 11h15 Francesca AMATI 
Department of Physiology - UNIL and 
Service of Endocrinology, Diabetology 
and Metabolism - CHUV 
Skeletal muscle mitochondrial content 
and electron transport chain activity in 
older adults at risk for type 2 diabetes: 
relationship to insulin sensitivity, 
metabolic flexibility and fatty acid 
oxidation 
11h15 – 11h30 Evrim JACCARD 
Departement of Physiology 
UNIL 
Involvement of the RasGAP-derived 
fragment N in the resistance of 
pancreatic beta cells towards apoptosis 
11h30 – 11h45 Luca CARIOLATO 
Institute of Pharmacology and 
Toxicology - UNIL  
Characterization of novel hypertrophic 
pathways activated by the AKAP-Lbc 
signalling complex in cardiomyocytes  
 
Afternoon 





European funding opportunities for health 
and health related research 
14h30 – 14h45 Mohammed NEMIR 
Experimental Cardiology Unit 
CHUV 
Cardiac-specific overexpression of the 
Notch ligand Jagged1 reduces cardiac 
hypertrophy and fibrosis in response to 
hemodynamic stress 
14h45 – 15h00 Hoshang FARHRAD 
Service of Nuclear Medicine 
CHUV 
Myocardial Blood Flow Quantification with 
Rubidium-82 Cardiac PET has 
Incremental Prognostic Value in Patients 
with Known or Suspected Coronary 
Artery Disease 
15h00 - 15h15 Muriel AUBERSON 
Department of Pharmacology and 
Toxicology - UNIL 
GLUT9 and uric acid handling by the 
kidney 
 
15h15 - 15h30 Fabienne MAURER 
Service of Medical Genetics 
CHUV 
Mapping genetic variants associated to 
beta-adrenergic responses in inbred mice 
15h30 – 15h45 
 
Maxime PELLEGRIN 
Service of Angiology 
CHUV 
Critical role of Angiotensin II type 1 
receptor on bone marrow-derived cells in 
the development of vulnerable 
atherosclerotic plaque in 2-Kidney, 1-Clip 
ApoE-/- mice 
 
